Shares of Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report) dropped 2.3% on Wednesday . The company traded as low as $1.25 and last traded at $1.28. Approximately 204,503 shares traded hands during mid-day trading, an increase of 871% from the average daily volume of 21,069 shares. The stock had previously closed at $1.31.
Bellevue Life Sciences Acquisition Stock Down 2.3%
The stock has a fifty day simple moving average of $1.34 and a two-hundred day simple moving average of $4.91.
Bellevue Life Sciences Acquisition Company Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Recommended Stories
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Investing in Construction Stocks
- Top 3 Bank Stocks to Watch as Fed Rate Cuts Loom
- What is the Hang Seng index?
- Uber and Tesla Surge on Robotaxis, Analyst Touts Texas Rides
- Stock Market Upgrades: What Are They?
- ASML Keeps Buying Back Its Own Stock—Chasing Discount and Upside
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
